DLC-1 (Loss of deleted in liver cancer-1) induced mitochondrial apoptosis, and inhibited EMT in nasopharyngeal carcinoma by targeting the EGFR/Akt/NF-κB pathway [35]. The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.